pelvic%20inflammatory%20disease
PELVIC INFLAMMATORY DISEASE
Pelvic inflammatory disease (PID) is the ascent of bacteria from the vagina or cervix resulting in infection of the reproductive organs eg uterus, fallopian tubes, ovaries. It may also be a complication of sexually transmitted infections.
The most common symptoms of PID are lower abdominal pain (crampy or dull) that usually starts a few days after the onset of the last menstrual period, dyspareunia, abnormal vaginal or cervical discharge, postcoital or irregular vaginal bleeding, dysuria, fever, nausea and vomiting, although some have minimal symptoms or silent pelvic inflammatory disease.

Follow Up

  • Further review 4 wk after treatment may be useful to ensure the following:
    • Adequate clinical response
    • Compliance w/ oral antibiotics
    • Screening & treatment of sex partners/contacts
    • Recurrence prevention through condom use
  • Repeat testing for etiologic organisms may be warranted for patients w/ persistent symptoms, poor compliance w/ antibiotics, or possible reinfection
    • In patients w/ documented infection w/ C trachomatis N gonorrhoeae, some specialists recommend rescreening 4-6 wk after completion of treatment

Counselling

  • STI consultation allows for an opportunity to discuss patient’s risk factors for STIs & HIV
  • Determine patient’s risk for HIV & discuss HIV testing
  • Testing for HIV is recommended & should be offered to all persons seeking evaluation & treatment for STIs
    • Pretest & posttest counseling as well as informed consent are part of the testing procedure
    • Concomitant infection w/ HIV may complicate management & control of some STIs
    • HIV-infected patients w/ PID are more common to have tubo-ovarian abscess & usually require surgical intervention
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS JPOG - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Rachel Soon, 5 days ago

On 8 August, the first town hall held by the Ministry of Health (MOH) with members of the pharmacy profession took place in Putrajaya. Over 500 pharmacists from across the country and from different areas of practice—community and hospital, public and private, academy and industry—converged to fill the auditorium for the chance to engage in direct dialogue with MOH.

Stephen Padilla, 6 days ago
Early administration of recombinant human B-type natriuretic peptide (rhBNP) can lower the incidence of reperfusion injury for patients with ST-elevation myocardial infarction (STEMI) who are receiving percutaneous coronary intervention (PCI) treatment, according to a China study.
11 Aug 2019
Intraoperative methylprednisolone does not appear to significantly prevent the incidence of death, cardiac arrest and other injuries in neonates undergoing cardiac surgery with cardiopulmonary bypass, according to a recent study.
3 days ago
Pulmonary function has potential predictive value for future increases in arterial stiffness and its progression, as reported in a recent study.